We next examined whether inhibition of GHSR1a has negative effects on ghrelin-induced alleviation of AD-like phenotypes using a GHSR1 antagonist, [D-Lys3]-growth hormone releasing peptide 6 (GHRP6) [36,51,52]. Here, GHRL is linked to Alzheimer disease.